{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:45:15Z","timestamp":1792615515069,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["154321"],"award-info":[{"award-number":["154321"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["192044"],"award-info":[{"award-number":["192044"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","award":["OG-3- 24-5819-DD"],"award-info":[{"award-number":["OG-3- 24-5819-DD"]}],"id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103115","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:05:04Z","timestamp":1792508704000},"page":"103115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury"],"prefix":"10.1016","author":[{"given":"Jacqueline A.","family":"Koehler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie L.","family":"Baggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiemin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2750-9039","authenticated-orcid":false,"given":"Rui","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Yusta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darleen A.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6688-8127","authenticated-orcid":false,"given":"Daniel J.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103115_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41574-019-0168-8","article-title":"Function and mechanisms of enteroendocrine cells and gut hormones in metabolism","volume":"15","author":"Gribble","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2026.103115_bib2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","article-title":"The expanding incretin universe: from basic biology to clinical translation","volume":"66","author":"Drucker","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.xcrm.2026.103115_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.103115_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41591-025-04124-5","article-title":"The expanding landscape of GLP-1 medicines","volume":"32","author":"Drucker","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103115_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/acsptsci.9b00016","article-title":"The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome","volume":"2","author":"Drucker","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.xcrm.2026.103115_bib6","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.immuni.2025.09.011","article-title":"Obesity, diabetes, and inflammation: Pathophysiology and clinical implications","volume":"58","author":"Donath","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103115_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103115_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib9","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","article-title":"GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation","volume":"22","author":"Bang-Berthelsen","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.xcrm.2026.103115_bib10","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.18632\/aging.204953","article-title":"The alleviating effect and mechanism of GLP-1 on ulcerative colitis","volume":"15","author":"Wang","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.xcrm.2026.103115_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/imm.13784","article-title":"GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells","volume":"172","author":"Sun","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2026.103115_bib12","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2012-303280","article-title":"Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis","volume":"62","author":"Kissow","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2026.103115_bib13","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/db14-1577","article-title":"GLP-1 receptor (GLP-1R) agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte (IEL) GLP-1R","volume":"64","author":"Yusta","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2026.103115_bib14","first-page":"E937","article-title":"Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis","volume":"277","author":"Boushey","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.xcrm.2026.103115_bib15","first-page":"687","article-title":"Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor","volume":"61","author":"Boushey","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103115_bib16","first-page":"G79","article-title":"Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis","volume":"276","author":"Drucker","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.xcrm.2026.103115_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00280-012-1882-2","article-title":"Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine","volume":"70","author":"Kissow","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.103115_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/en.2013-1871","article-title":"The intestinal epithelial insulin-like growth factor-1 receptor links glucagon-like peptide-2 action to gut barrier function","volume":"155","author":"Dong","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.103115_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1210\/en.2011-1954","article-title":"Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis","volume":"153","author":"Lee","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.103115_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102311","article-title":"Loss of GLP-2R signaling in Glp2r(-\/-) mice increases the long-term severity of graft versus host disease","volume":"103","author":"Yusta","year":"2026","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib21","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa246","article-title":"Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice","volume":"162","author":"Andersen","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.103115_bib22","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1210\/en.2019-00398","article-title":"Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse","volume":"160","author":"Yusta","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2026.103115_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2004.07.009","article-title":"GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors","volume":"124","author":"\u00d8rskov","year":"2005","journal-title":"Regul. Pept."},{"key":"10.1016\/j.xcrm.2026.103115_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2005.11.005","article-title":"GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow","volume":"130","author":"Guan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.103115_bib25","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/s41590-025-02328-y","article-title":"TSLP links intestinal nutrient sensing with amplification of the ILC2-tuft cell circuit","volume":"26","author":"Liao","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103115_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.1600185","article-title":"The Cytosolic Microbial Receptor Nod2 Regulates Small Intestinal Crypt Damage and Epithelial Regeneration following T Cell-Induced Enteropathy","volume":"197","author":"Zanello","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.103115_bib27","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI0215695","article-title":"T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+\/K+-ATPase","volume":"110","author":"Musch","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103115_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cmet.2019.08.009","article-title":"Gut-Proglucagon-Derived Peptides Are Essential for Regulating Glucose Homeostasis in Mice","volume":"30","author":"Song","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib29","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","article-title":"The role of pancreatic preproglucagon in glucose homeostasis in mice","volume":"25","author":"Chambers","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2008.07.027","article-title":"New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity","volume":"274","author":"Ochi","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.xcrm.2026.103115_bib31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103115_bib32","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.2337\/db14-0100","article-title":"GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering","volume":"63","author":"Kahles","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2026.103115_bib33","doi-asserted-by":"crossref","first-page":"G205","DOI":"10.1152\/ajpgi.00337.2021","article-title":"Feeding mode influences dynamic gut microbiota signatures and affects susceptibility to anti-CD3 mAb-induced intestinal injury in neonatal mice","volume":"323","author":"Subramanian","year":"2022","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.xcrm.2026.103115_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mucimm.2023.02.001","article-title":"ATG16L1 protects from interferon-gamma-induced cell death in the small intestinal crypt","volume":"16","author":"Foerster","year":"2023","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.xcrm.2026.103115_bib35","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon-like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103115_bib36","doi-asserted-by":"crossref","first-page":"G1202","DOI":"10.1152\/ajpgi.90494.2008","article-title":"Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2","volume":"295","author":"Ivory","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.xcrm.2026.103115_bib37","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41467-026-68551-9","article-title":"Microbial activation of the GLP-2R mitigates gastrointestinal inflammation","volume":"17","author":"Yang-Jensen","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103115_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac544.3004","article-title":"GLP-2 as an indicator and modulator of acute inflammation improves cardiac function and survival in sepsis","volume":"43","author":"Kahles","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.103115_bib39","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2009.05.057","article-title":"ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut","volume":"137","author":"Yusta","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.103115_bib40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/BF01073027","article-title":"Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides","volume":"21","author":"O'Dorisio","year":"1976","journal-title":"Am. J. Dig. Dis."},{"key":"10.1016\/j.xcrm.2026.103115_bib41","article-title":"Lgr5+ Stem Cells Maintain Apex Position in Cell Hierarchy of the Intestinal Epithelium During Homeostasis and Injury","author":"Chua","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.103115_bib42","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cmet.2022.08.003","article-title":"Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation","volume":"34","author":"Wong","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib43","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103115_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.molmet.2017.04.007","article-title":"The endogenous preproglucagon system is not essential for gut growth homeostasis in mice","volume":"6","author":"Wismann","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129452","article-title":"Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy","volume":"4","author":"Kim","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.103115_bib46","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1111\/all.16402","article-title":"Endogenous Glucagon-Like Peptide-1 Receptor and Glucose-Dependent Insulinotropic Polypeptide Receptor Signaling Inhibits Aeroallergen-Induced Innate Airway Inflammation","volume":"79","author":"Toki","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.xcrm.2026.103115_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ajpath.2019.10.008","article-title":"Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation","volume":"190","author":"Moschovaki Filippidou","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.103115_bib48","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/ni1008-1091","article-title":"The Immunological Genome Project: networks of gene expression in immune cells","volume":"9","author":"Heng","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103115_bib49","doi-asserted-by":"crossref","first-page":"G211","DOI":"10.1152\/ajpgi.00530.2006","article-title":"Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2","volume":"293","author":"Sigalet","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.xcrm.2026.103115_bib50","doi-asserted-by":"crossref","first-page":"G288","DOI":"10.1152\/ajpgi.00453.2006","article-title":"Exendin-4, but not dipeptidyl peptidase IV inhibition, increases small intestinal mass in GK rats","volume":"293","author":"Simonsen","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.xcrm.2026.103115_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2015.02.005","article-title":"GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7","volume":"21","author":"Koehler","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102235","article-title":"GLP-1R signaling does not modify the severity of experimental graft versus host disease","volume":"100","author":"Yusta","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood.2020005957","article-title":"Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans","volume":"136","author":"Norona","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.103115_bib54","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/ibd.21117","article-title":"Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease","volume":"16","author":"Buchman","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.xcrm.2026.103115_bib55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ibd\/izaf301","article-title":"Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis","volume":"32","author":"Desai","year":"2026","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.xcrm.2026.103115_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf181","article-title":"Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Bayoumy","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.xcrm.2026.103115_bib57","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1111\/dom.70034","article-title":"Impact of glucagon-like peptide-1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes","volume":"27","author":"Yen","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103801","article-title":"Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial","volume":"93","author":"Nielsen","year":"2026","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.xcrm.2026.103115_bib59","article-title":"Bispecific GLP-1\/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial","volume":"17","author":"Yang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103115_bib60","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103115_bib61","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cmet.2026.07.006","article-title":"Weight-loss-independent actions of GLP-1 medicines","volume":"38","author":"Gonzalez-Rellan","year":"2026","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib62","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/nm1196-1254","article-title":"Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene","volume":"2","author":"Scrocchi","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103115_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.103115_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.103115_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061217","article-title":"phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.103115_bib66","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.103115_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for prediction of metagenome functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103115_bib68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.103115_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.100990","article-title":"Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion","volume":"37","author":"Panaro","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.xcrm.2026.103115_bib70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/00365527809181758","article-title":"Passage of Molecules through the Wall of the Gastrointestinal Tract","volume":"13","author":"Tagesson","year":"1978","journal-title":"Scand. J. Gastroenterol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:01:35Z","timestamp":1792612895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912600532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":70,"alternative-id":["S266637912600532X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103115","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut-derived glucagon-like peptides attenuate T cell-induced intestinal injury","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103115"}}